In order to be able to understand the best proteins that could bind to these domains and help stop the spread of the virus, many researchers have begun to use molecular docking techniques to identify proteins that can be used to inhibit the SARS-CoV-2 spike and ACE2 binding and consequent formation of their complex . One such study by Smith and Smith at the Oak Ridge National Laboratory found that the highest binding compound evaluated for potential use in future studies could be Pemirolast, an anti-allergy medication . However, there has yet to be a docking study of hydroxychloroquine and its effect on SARS-CoV-2 spike -ACE2 domains.